Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence

被引：130

作者：

Maurer, M. ^{[1
]}

Metz, M. ^{[1
]}

Bindslev-Jensen, C. ^{[2
,18
]}

Bousquet, J. ^{[3
,4
,5
]}

Canonica, G. W. ^{[6
]}

Church, M. K. ^{[1
]}

Godse, K. V. ^{[7
]}

Grattan, C. E. ^{[8
]}

Hide, M. ^{[9
]}

Kocaturk, E. ^{[10
]}

Magerl, M. ^{[1
]}

Makris, M. ^{[11
]}

Meshkova, R. ^{[12
]}

Saini, S. S. ^{[13
]}

Sussman, G. ^{[14
]}

Toubi, E. ^{[15
]}

Zhao, Z. ^{[16
]}

Zuberbier, T. ^{[1
]}

Gimenez-Arnau, A. ^{[17
]}

机构：

[1] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, Charite Pl 1, D-10117 Berlin, Germany

[2] Odense Univ Hosp, Dept Dermatol, Odense Res Ctr Anaphylaxis, Odense, Denmark

[3] Univ Hosp, Montpellier, France

[4] INSERM, VIMA Ageing & Chron Dis, Epidemiol & Publ Hlth Approaches, Paris, France

[5] Univ Versailles St Quentin En Yvelines, UVSQ, UMR S 1168, St Quentin En Yvelines, France

[6] Univ Genoa, IRCCS AOU San Martino IST, Genoa, Italy

[7] DY Patil Sch Med, Dept Dermatol, Nerul, Navi Mumbai, India

[8] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England

[9] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dermatol, Hiroshima, Japan

[10] Okmeydani Training & Res Hosp, Dept Dermatol, Istanbul, Turkey

[11] Attikon Univ Hosp, Dept Dermatol & Venereol 2, Athens, Greece

[12] Smolensk State Med Univ, Dept Clin Immunol & Allergy, Smolensk, Russia

[13] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[14] Univ Toronto, Div Allergy & Immunol, Toronto, ON, Canada

[15] Technion Israel Inst Technol, Allergy & Clin Immunol, Bnai Zion Med Ctr, Haifa, Israel

[16] Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing, Peoples R China

[17] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, IMIM, Barcelona, Spain

[18] Odense Univ Hosp, Allergy Ctr, Odense Res Ctr Anaphylaxis, Odense, Denmark

来源：

ALLERGY | 2016年 / 71卷 / 08期

关键词：

angioedema; center; excellence; management; urticaria; QUALITY-OF-LIFE; VALIDATION; OMALIZUMAB; INSTRUMENT; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; NETWORK;

D O I：

10.1111/all.12901

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

BackgroundGA(2)LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. AimsHere, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA(2)LEN UCAREs. ResultsThe main aims of GA(2)LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA(2)LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and ConclusionThe GA(2)LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.

引用

页码：1210 / 1218

页数：9

共 50 条

[21] Adaptation and initial results of the Polish version of the GA2LEN Chronic Urticaria Quality Of Life Questionnaire (CU-Q2oL)
Brzoza, Z.
Badura-Brzoza, K.
Mlynek, A.
Magerl, M.
Baiardini, I.
Canonica, G. W.
Weller, K.
Kocaturk, E.
Kalogeromitros, D.
Zalewska-Janowska, A.
Zuberbier, T.
Maurer, M.
JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 62 (01) : 36 - 41
[22] Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper
Bousquet, J.
Schunemann, H. J.
Zuberbier, T.
Bachert, C.
Baena-Cagnani, C. E.
Bousquet, P. J.
Brozek, J.
Canonica, G. W.
Casale, T. B.
Demoly, P.
Gerth van Wijk, R.
Ohta, K.
Bateman, E. D.
Calderon, M.
Cruz, A. A.
Dolen, W. K.
Haughney, J.
Lockey, R. F.
Lotvall, J.
O'Byrne, P.
Spranger, O.
Togias, A.
Bonini, S.
Boulet, L. P.
Camargos, P.
Carlsen, K. H.
Chavannes, N. H.
Delgado, L.
Durham, S. R.
Fokkens, W. J.
Fonseca, J.
Haahtela, T.
Kalayci, O.
Kowalski, M. L.
Larenas-Linnemann, D.
Li, J.
Mohammad, Y.
Mullol, J.
Naclerio, R.
O'Hehir, R. E.
Papadopoulos, N.
Passalacqua, G.
Rabe, K. F.
Pawankar, R.
Ryan, D.
Samolinski, B.
Simons, F. E. R.
Valovirta, E.
Yorgancioglu, A.
Yusuf, O. M.
ALLERGY, 2010, 65 (10) : 1212 - 1221
[23] Efficacy of Desloratadine in Persistent Allergic Rhinitis - A GA2LEN Study
Bousquet, Jean
Bachert, Claus
Canonica, Giorgio W.
Mullol, Joaquim
Van Cauwenberge, Paul
Jensen, Carsten Bindslev
Fokkens, Wystke J.
Ring, Johannes
Keith, Paul
Gopalan, Gokul
Lorber, Richard
Zuberbier, Torsten
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 153 (04) : 395 - 402
[24] The prevalence of asthma in adult population of southwestern Iran and its association with chronic rhinosinusitis: a GA2LEN study
Ostovar, Afshin
Fokkens, Wytske J.
Pordel, Safoora
Movahed, Ali
Ghasemi, Khadijeh
Marzban, Maryam
Farrokhi, Shokrollah
CLINICAL AND TRANSLATIONAL ALLERGY, 2019, 9 (01)
[25] The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T.
Aberer, W.
Asero, R.
Bindslev-Jensen, C.
Brzoza, Z.
Canonica, G. W.
Church, M. K.
Ensina, L. F.
Gimenez-Arnau, A.
Godse, K.
Goncalo, M.
Grattan, C.
Hebert, J.
Hide, M.
Kaplan, A.
Kapp, A.
Latiff, A. H. Abdul
Mathelier-Fusade, P.
Metz, M.
Nast, A.
Saini, S. S.
Sanchez-Borges, M.
Schmid-Grendelmeier, P.
Simons, F. E. R.
Staubach, P.
Sussman, G.
Toubi, E.
Vena, G. A.
Wedi, B.
Zhu, X. J.
Maurer, M.
PRZEGLAD DERMATOLOGICZNY, 2015, 102 (02): : 155 - 179
[26] Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
Bousquet, J.
Bachert, C.
Canonica, G. W.
Mullol, J.
Van Cauwenberge, P.
Jensen, C. Bindslev
Fokkens, W. J.
Ring, J.
Keith, P.
Lorber, R.
Zuberbier, T.
ALLERGY, 2009, 64 (10) : 1516 - 1523
[27] Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review
Zuberbier, T.
Loetvall, J.
Simoens, S.
Subramanian, S. V.
Church, M. K.
ALLERGY, 2014, 69 (10) : 1275 - 1279
[28] EEAGI/GA(2)LEN/EDF/WAO Guidelines pertaining to the definition, classification, diagnosis and management of urticaria: 2013 revision and update
Zuberbier, T.
Aberer, W.
Asero, R.
Bindslev-Jensen, C.
Brzoza, Z.
Canonica, G. W.
Church, M. K.
Ensina, L. F.
Gimenez-Arnau, A.
Godse, K.
Goncalo, M.
Grattan, C.
Hebert, J.
Hide, M.
Kaplan, A.
Kapp, A.
Latiff, A. H. Abdul
Mathelier-Fusade, P.
Metz, M.
Nast, A.
Saini, S. S.
Sanchez-Borges, M.
Schmid-Grendelmeier, P.
Simons, F. E. R.
Staubach, P.
Sussman, G.
Toubi, E.
Vena, G. A.
Wedi, B.
Zhu, X. J.
Maurer, M.
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2015, 2 (01) : T1 - T23
[29] The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school
Muraro, A.
Clark, A.
Beyer, K.
Borrego, L. M.
Borres, M.
Carlsen, K. C. Lodrup
Carrer, P.
Mazon, A.
Rance, F.
Valovirta, E.
Wickman, M.
Zanchetti, M.
ALLERGY, 2010, 65 (06) : 681 - 689
[30] Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GA2LEN platform. The Galenda project
Bousquet, P. -J.
Demoly, P.
Romano, A.
Aberer, W.
Bircher, A.
Blanca, M.
Brockow, K.
Pichler, W.
Torres, M. J.
Terreehorst, I.
Arnoux, B.
Atanaskovic-Markovic, M.
Barbaud, A.
Bijl, A.
Bonadonna, P.
Burney, P. G.
Caimmi, S.
Canonica, G. W.
Cernadas, J.
Dahlen, B.
Daures, J. -P.
Fernandez, J.
Gomes, E.
Gueant, J. -L.
Kowalski, M. L.
Kvedariene, V.
Mertes, P. -M.
Martins, P.
Nizankowska-Mogilnicka, E.
Papadopoulos, N.
Ponvert, C.
Pirmohamed, M.
Ring, J.
Salapatas, M.
Sanz, M. L.
Szczeklik, A.
Van Ganse, E.
De Weck, A. L.
Zuberbier, T.
Merk, H. F.
Sachs, B.
Sidoroff, A.
ALLERGY, 2009, 64 (02) : 194 - 203

← 1 2 3 4 5 →